Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,325,264
  • Shares Outstanding, K 122,181
  • Annual Sales, $ 9,437 M
  • Annual Income, $ 1,431 M
  • 60-Month Beta 1.04
  • Price/Sales 1.83
  • Price/Cash Flow 10.08
  • Price/Book 2.91
Trade DGX with:

Options Overview

Details
  • Implied Volatility 17.91%
  • Historical Volatility 10.44%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 41.31% on 10/30/20
  • IV Low 17.91% on 07/30/21
  • Put/Call Vol Ratio 0.68
  • Today's Volume 411
  • Volume Avg (30-Day) 752
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 25,733
  • Open Int (30-Day) 26,150

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 2.20
  • Number of Estimates 8
  • High Estimate 2.28
  • Low Estimate 2.03
  • Prior Year 4.31
  • Growth Rate Est. (year over year) -48.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.86 +7.54%
on 07/01/21
142.48 -0.48%
on 07/30/21
+9.83 (+7.45%)
since 06/30/21
3-Month
126.24 +12.33%
on 06/17/21
142.80 -0.70%
on 05/10/21
+9.92 (+7.52%)
since 04/30/21
52-Week
104.10 +36.22%
on 08/27/20
142.80 -0.70%
on 05/10/21
+15.04 (+11.86%)
since 07/30/20

Most Recent Stories

More News
Cervical Dysplasia Market top players, Cervical Dysplasia Market COVID Impact, Cervical Dysplasia Market Forecast, Cervical Dysplasia Market SWOT Analysis, Cervical Dysplasia Market Opportunity, Cervical Dysplasia Market Demand, Cervical Dysplasia Market Trends, Cervical Dysplasia Market Industry Growth Market future prospects, growth opportunities and outlook (2021-2028) shared in trending report

The global size is expected to reach USD 955 million by 2028 according to a new study by. Worldwide Cervical Dysplasia Market Analysis, 2021 research report portrays a profound plunge of market investigation...

HOLX : 75.04 (+1.65%)
DGX : 141.80 (+0.40%)
COVID-19 Sample Collection Kits Market - Detailed analysis of current industry figures with growth opportunities and forecasts growth by 2028

The global size is expected to reach USD 18.23 billion by 2028 according to a new study by . Worldwide COVID-19 Sample Collection Kits Market Analysis, 2021 research report portrays a profound plunge...

LH : 296.15 (+0.51%)
DGX : 141.80 (+0.40%)
TRIB : 2.19 (+10.05%)
Will Quest Diagnostics Stock Continue to Climb?

The share price of leading diagnostic information services provider Quest Diagnostics (DGX) has been surging as the spread of the COVID-19 Delta variant across the United States increases COVID-19 testing...

DGX : 141.80 (+0.40%)
Medical Device Stocks' Earnings on Jul 28: TMO, ALGN & More

The sector's Q2 results are likely to reflect solid earnings and revenue growth on strong base business recovery.

ABT : 120.98 (-0.09%)
DGX : 141.80 (+0.40%)
ALGN : 695.80 (+2.78%)
TMO : 540.01 (+1.17%)
HOLX : 75.04 (+1.65%)
IART : 72.39 (+1.83%)
Quest Diagnostics (DGX) Q2 Earnings Beat, Base Testing Strong

According to Quest Diagnostics (DGX), Q2 is the first quarter since 2019 in which it has registered organic base testing revenue growth.

DGX : 141.80 (+0.40%)
ALGN : 695.80 (+2.78%)
AMN : 100.56 (+0.58%)
CTLT : 119.81 (+0.41%)
Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 10.80% and 6.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

DGX : 141.80 (+0.40%)
Quest Diagnostics: Q2 Earnings Snapshot

SECAUCUS, N.J. (AP) _ Quest Diagnostics Inc. (DGX) on Thursday reported second-quarter net income of $631 million.

DGX : 141.80 (+0.40%)
Quest Diagnostics Reports Second Quarter 2021 Financial Results; Establishes Full Year 2021 Outlook

July 22, 2021 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the second quarter ended...

DGX : 141.80 (+0.40%)
Report 2021, Cervical Cancer Screening Market | Global Size, Share, Growth, Trends, Revenue Analysis, Competitive Landscape, Forecast 2028

The global cervical cancer screening market size is expected to gain momentum owing to the increasing prevalence of cancer during the forecast period. This information is published by Fortune Business...

ADXS : 0.4100 (-0.49%)
MRK : 76.87 (-0.08%)
PFE : 42.81 (+0.05%)
DGX : 141.80 (+0.40%)
Quest Diagnostics (DGX) Expands Testing Access With CLX Pact

Quest Diagnostics' (DGX) COVID-19 testing will be available through TrustAssure platform for international travelers and live event attendants.

LH : 296.15 (+0.51%)
DGX : 141.80 (+0.40%)
NVST : 43.08 (+1.08%)
BRBR : 33.07 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Key Turning Points

3rd Resistance Point 144.15
2nd Resistance Point 143.31
1st Resistance Point 142.56
Last Price 141.80
1st Support Level 140.97
2nd Support Level 140.13
3rd Support Level 139.38

See More

52-Week High 142.80
Last Price 141.80
Fibonacci 61.8% 128.02
Fibonacci 50% 123.45
Fibonacci 38.2% 118.88
52-Week Low 104.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar